Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Biosyntia logo — Our uniqueness is our technology

Biosyntia

Our uniqueness is our technology

Founded 2012 Denmark Denmark 23 employees Series B Total: $17.37M Biopharma, Biotechnology +1

General Information

Company Name Biosyntia
Founded Year 2012
Location Denmark Denmark
Employees 23
Industries Biopharma, Biotechnology, Manufacturing
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Biosyntia. To contact Biosyntia, visit biosyntia.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Biosyntia compare?

A PDF of Biosyntia and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Biosyntia soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Biosyntia

Biosyntia, a biotech startup founded in 2012 and headquartered in Denmark, has attracted significant attention with its latest €11.50M Series B investment on 06 July 2022. The company's prowess lies in its synthetic biology and metabolic engineering capabilities, allowing for the rapid development of biocatalysts through its patent-pending high-throughput screening technology. This cutting-edge approach enables Biosyntia to tailor processes based on biocatalysis, facilitating the production of complex chemical compounds through fermentation. By partnering with manufacturers of fine chemical compounds, Biosyntia aims to promote sustainable manufacturing processes to reduce environmental impact. The backing of renowned investors such as Novo Holdings, Sofinnova Partners, ECBF reflects the potential seen in Biosyntia's technology and its impact on the fields of biopharma, biotechnology, and manufacturing. Situated in the vibrant startup incubator Symbion in Copenhagen, Biosyntia's dedication to innovative, sustainable solutions positions it as a promising player in the industry.

Business keywords: biotech, synthetic biology, metabolic engineering, biocatalysts, high-throughput screening technology, tailored processes, fermentation, fine chemical compounds, sustainable manufacturing processes, green technology, startup incubator, Copenhagen, chemical synthesis

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series B €11.50M 3
Novo Holdings Sofinnova Partners ECBF
Novo Holdings, Sofinnova Partners +1
06 Jul 2022
Series A €4.00M 2
Novo Holdings Sofinnova Partners
Novo Holdings, Sofinnova Partners
23 May 2018
Seed Round $1.87M 2
Novo Holdings
Novo Holdings, Novo Ventures
21 May 2015

Biosyntia Alternatives & Competitors

View All Alternatives
Biosyntia vs
ecovia bio
ecovia bio United States

Making better biobased ingredients and materials through sustainable innovation 🌿

Venture round
12 employees
Agriculture, Biotechnology
Biosyntia vs
synplogen
synplogen

Pioneering advanced DNA synthesis with a decade of innovation in genetic engineering, information sc...

2 employees
Biopharma, Biotechnology
Biosyntia vs
Antheia, Inc.
Antheia, Inc. United States

The advanced biosynthesis company delivering 21st-century pharmaceutical manufacturing and innovatio...

Series C
66 employees
Biotechnology, Health Care
View all alternatives

FAQ About Biosyntia

Our uniqueness is our technology
Biosyntia was founded in 2012.
Biosyntia is headquartered in Denmark.
Biosyntia operates in Biopharma, Biotechnology and Manufacturing. Its work centres on biotech, synthetic biology, metabolic engineering and biocatalysts.
Biosyntia has approximately 23 employees.
Biosyntia has completed 3 funding rounds, raising a total of $17.37M. The latest funding stage is Series B.
Top alternatives and competitors to Biosyntia include ecovia bio, synplogen, Antheia, Inc., Evonetix Ltd, Solugen. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Biosyntia and ecovia bio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Biosyntia, https://bouncewatch.com/company/biosyntia, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout